Home » Topics » Regulatory » Patents

Patents
RSS

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Kureha glycoproteins show antitumor and immunomodulatory effects

Sep. 27, 1996

Sankyo discloses anthelmintic agents

Sep. 27, 1996

Anti-HIV agents reported by Japanese researchers

Sep. 27, 1996

A novel mechanism for inhibiting HIV infection using fibronectin fragments

Sep. 27, 1996

Anti-HIV research continues at Boehringer Ingelheim

Sep. 27, 1996

Anti-HIV bicyclic phosphoramides from DuPont Merck

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...